China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2025)

China SXT Pharmaceuticals (SXTC) recorded quarterly Debt Ratio of 0.0 in Q3 2025, down 39.29% quarter-over-quarter from 0.0 in Q1 2025, and down 26.66% on a YoY basis from 0.0 in Q3 2024.

China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2025) Analysis & Trends

China SXT Pharmaceuticals' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q3 2025.

  • In Q3 2025, Debt Ratio fell 26.66% year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (down 26.66% YoY), while the FY2025 annual figure was 0.0, down 81.62% from the prior year.
  • Debt Ratio was 0.0 for Q3 2025 at China SXT Pharmaceuticals, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.35 in Q1 2021 to a low of 0.0 in Q1 2022.
  • Historically, Debt Ratio has averaged 0.06 across 5 years, with a median of 0.01 in 2023.
  • The sharpest annual moves came in 2021 and 2022: Debt Ratio jumped 3583.35% in 2021, then slumped 99.9% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.09 in 2021, then slumped by 41.79% to 0.05 in 2022, then tumbled by 84.08% to 0.01 in 2023, then plunged by 53.64% to 0.0 in 2024, then retreated by 26.66% to 0.0 in 2025.
  • The last three Debt Ratio figures came in at 0.0 (Q3 2025), 0.0 (Q1 2025), and 0.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 China SXT Pharmaceuticals 187.96 Mn 166.77 Mn - 0.00

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Mar 31, 2025 0.00
Sep 30, 2024 0.00
Mar 31, 2024 0.03
Sep 30, 2023 0.01
Mar 31, 2023 0.01
Sep 30, 2022 0.05
Mar 31, 2022 0.00
Sep 30, 2021 0.09
Mar 31, 2021 0.35
Sep 30, 2020 0.00
Mar 31, 2020 0.31
Sep 30, 2019 0.08
Mar 31, 2019 0.14
Sep 30, 2018 0.03